Graham Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,887
Closed -$935K 1392
2025
Q4
$935K Sell
8,887
-6,124
-41% -$575K 0.02% 408
2025
Q3
$1.26M Buy
+15,011
New +$1.24M 0.02% 316
2025
Q2
Sell
-96,589
Closed -$8.67M 1484
2025
Q1
$8.67M Buy
+96,589
New +$9.02M 0.15% 74
2024
Q4
Sell
-43,756
Closed -$4.97M 1385
2024
Q3
$4.97M Buy
43,756
+36,033
+467% +$4.28M 0.09% 127
2024
Q2
$956K Buy
+7,723
New +$995K 0.02% 432
2024
Q1
Sell
-20,218
Closed -$2.2M 1218
2023
Q4
$2.2M Sell
20,218
-48,437
-71% -$5.03M 0.05% 197
2023
Q3
$7.07M Buy
+68,655
New +$7.4M 0.17% 93
2023
Q2
Sell
-10,125
Closed -$1.08M 1177
2023
Q1
$1.08M Sell
10,125
-2,046
-17% -$221K 0.03% 477
2022
Q4
$1.35M Sell
12,171
-929
-7% -$95K 0.04% 425
2022
Q3
$1.13M Buy
13,100
+213
+2% +$19K 0.04% 433
2022
Q2
$1.17M Sell
12,887
-9,830
-43% -$871K 0.05% 385
2022
Q1
$1.86M Buy
22,717
+19,728
+660% +$1.56M 0.06% 144
2021
Q4
$229K Buy
+2,989
New +$238K 0.01% 417
2019
Q4
Sell
-83,840
Closed -$6.73M 90
2019
Q3
$6.73M Hold
83,840
0.22% 59
2019
Q2
$6.71M Buy
+83,840
New +$6.42M 0.2% 49
2017
Q3
Sell
-18,969
Closed -$1.16M 77
2017
Q2
$1.16M Buy
+18,969
New +$1.15M 0.03% 56
2015
Q4
Sell
-23,370
Closed -$1.1M 72
2015
Q3
$1.1M Buy
+23,370
New +$1.24M 0.13% 88
2015
Q1
Sell
-52,400
Closed -$2.84M 143
2014
Q4
$2.84M Buy
+52,400
New +$2.92M 0.12% 99

Other funds holding MRK

Graham Capital Management's MRK Position: Q1 2026 in Review

Graham Capital Management sold out of Merck (MRK) in Q1 2026, closing a stake of 8,887 shares — an estimated $935K sold.

Graham Capital Management first reported a position in MRK in Q4 2014 and held it in 18 quarters. The position peaked at $8.67M in Q1 2025. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Graham Capital Management reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Graham Capital Management sold 8,887 Merck shares in Q1 2026, an estimated $935K.
  • Graham Capital Management first reported a position in Merck in Q4 2014 and held it in 18 quarters.
  • Graham Capital Management's Merck position peaked at $8.67M in Q1 2025.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.